{"id":3750,"date":"2020-08-26T09:16:52","date_gmt":"2020-08-26T09:16:52","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/multiplex-assay-for-10-stis-receives-ce-mark\/"},"modified":"2021-01-08T11:20:37","modified_gmt":"2021-01-08T11:20:37","slug":"multiplex-assay-for-10-stis-receives-ce-mark","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/multiplex-assay-for-10-stis-receives-ce-mark\/","title":{"rendered":"Multiplex assay for 10 STI\u2019s receives CE mark"},"content":{"rendered":"<p>CE marking has been granted to one of the most comprehensive cartridge-based STI tests. The test, developed by the UK\u2019s largest health diagnostics company, Randox Laboratories, tests simultaneously for 10 of the most common sexually transmitted infections, on the firm\u2019s patented Biochip Technology. Quickly and efficiently testing for multiple STIs, which often have mild symptoms if any at all, ensures early diagnosis at a stage when treatment is most successful, supports the targeted use of antibiotics, and ultimately reduces their mishandling. Dr Peter FitzGerald, Managing Director of Randox Laboratories, commented; \u201cAntibiotic stewardship is a critical issue which we all have a responsibility to embrace and drive forward. The CE marking of the STI assay, which incorporates Randox Biochip Technology, will be a game-changer for clinicians and patients across Europe, by facilitating early, accurate and comprehensive diagnoses of STIs that allows for the best possible patient outcome. Never before has there been this level of accessibility and speed with regards to STI testing.\u201d<br \/>\nThe Randox STI assay is performed on the Vivalytic system, an intuitive point-of-care platform, developed in partnership with German technology company Bosch that provides the broadest range of test options ever seen for an analyser of its size. Harnessing the application of multiplex assays to provide greater information from a single patient sample, the Vivalytic simplifies the testing process for otherwise complex laboratory testing procedures.<br \/>\nMarc Meier, Managing Director of Bosch Healthcare Solutions, a subsidiary of Bosch Group, said: \u201cWe are enthusiastic about partnering with Randox to offer their assay technology on the Vivalytic platform. The core competencies of Bosch in automation, miniaturization, sensor technology and connectivity are complemented by Randox\u2019s expertise in developing excellent biocontent for a wide range of assays and commercializing innovative diagnostic solutions.\u201d<br \/>\n<!--more--><br \/>\n<strong>Supplier:<\/strong> [No title]<br \/>\n<strong>Website:<\/strong> <a href=\"https:\/\/www.bosch-healthcare.com\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.bosch-healthcare.com<\/a><\/p>\n<p><a class=\"avia-button avia-color-theme-color\" href=\"mailto:\">Mail the supplier<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CE marking has been granted to one of the most comprehensive cartridge-based STI tests. The test, developed by the UK\u2019s largest health diagnostics company, Randox Laboratories, tests simultaneously for 10 of the most common sexually transmitted infections, on the firm\u2019s patented Biochip Technology. Quickly and efficiently testing for multiple STIs, which often have mild symptoms [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":11187,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-3750","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/3750"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=3750"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/3750\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/11187"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=3750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=3750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=3750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}